There are still lots of ambiguities w/ #RightToTry that need to be worked out. But that was the burden @SGottliebFDA committed the #FDA to take on when he decided to back the law, saying he was "comfortable" with it & walked away from his earlier concerns.
#pharma #biotech
Story notes: There is no government agency or other entity charged w/ confirming beforehand that the price the company is seeking to charge under the #RightToTry law does not exceed the product's direct costs, though [Zettler] said the FDA may be able to check that after the facthttps://twitter.com/gorskon/status/1010156123809296384 …
-
-
Show this threadThanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.